Trial registration [3]

New England Journal of Medicine

Volumn 356, Issue 15, 2007, Pages 1581-

  Lott, Jason P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DATA BASE; DRUG INDUSTRY; LAW; LEGAL ASPECT; LETTER; MEDICAL SOCIETY; PRIORITY JOURNAL; REGISTRATION; UNITED STATES; CLINICAL TRIAL; HUMAN; NOTE; PUBLISHING; REGISTER;

CLINICAL TRIALS; DATABASES; DRUG INDUSTRY; EDITORIAL POLICIES; HUMANS; REGISTRIES; UNITED STATES;

EID: 34247102694     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070302     Document Type: Letter

References (5)

1. Drazen JM, Zarin DA. Salvation by registration. N Engl J Med 2007;356:184-5.
2. Lott JP, Katz KA. Pharmaceutical companies' policies and practices regarding prospective registration of dermatologyrelated clinical trials. Br J Dermatol 2006;155:635-8.
3. De Angelis C, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med 2004;351:1250-1.
4. Steinbrook R. Registration of clinical trials - voluntary or mandatory? N Engl J Med 2004;351:1820-2.
5. Henderson JK, Cassady Q. Drug deals 2006: cutting edge legal and regulatory issues in the pharmaceutical industry. Ann Health Law 2006;15:107-49.